Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/107534
Title: Cooperative Transcription Factor Induction Mediates Hemogenic Reprogramming
Authors: Gomes, Andreia 
Kurochkin, Ilia
Chang, Betty
Daniel, Michael
Law, Kenneth
Satija, Namita
Lachmann, Alexander
Wang, Zichen
Ferreira, Lino 
Ma'ayan, Avi
Chen, Benjamin K.
Papatsenko, Dmitri
Lemischka, Ihor R
Moore, Kateri A.
Pereira, Carlos Filipe 
Keywords: FOS; GATA2; GFI1B; cooperative binding; direct cell reprogramming; hematopoietic stem cell; hematopoietic transcription factor; hemogenic endothelium; hemogenic reprogramming; human endothelial-to-hematopoietic transition
Issue Date: 4-Dec-2018
Publisher: Elsevier
Project: NIH ( 1R01HL119404 to K.A.M. and I.R.L.) 
NIH /IAD (R33A1116191 to B.K.C) 
New York Dept. of Health NYSTEM ( C32597GG to K.A.M.) 
Charles H. Revson Foundation 
European Commission ( PIIF-GA-2013-628761 to C.-F.P.) 
FCT - SFRH/BD/51968/2012 and PTDC/BIM-MED/0075/2014 to A.M.G. and C.-F.P.) 
metadata.degois.publication.title: Cell Reports
metadata.degois.publication.volume: 25
metadata.degois.publication.issue: 10
Abstract: During development, hematopoietic stem and progenitor cells (HSPCs) arise from specialized endothelial cells by a process termed endothelial-to-hematopoietic transition (EHT). The genetic program driving human HSPC emergence remains largely unknown. We previously reported that the generation of hemogenic precursor cells from mouse fibroblasts recapitulates developmental hematopoiesis. Here, we demonstrate that human fibroblasts can be reprogrammed into hemogenic cells by the same transcription factors. Induced cells display dynamic EHT transcriptional programs, generate hematopoietic progeny, possess HSPC cell surface phenotype, and repopulate immunodeficient mice for 3 months. Mechanistically, GATA2 and GFI1B interact and co-occupy a cohort of targets. This cooperative binding is reflected by engagement of open enhancers and promoters, initiating silencing of fibroblast genes and activating the hemogenic program. However, GATA2 displays dominant and independent targeting activity during the early phases of reprogramming. These findings shed light on the processes controlling human HSC specification and support generation of reprogrammed HSCs for clinical applications.
URI: https://hdl.handle.net/10316/107534
ISSN: 22111247
DOI: 10.1016/j.celrep.2018.11.032
Rights: openAccess
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais

Files in This Item:
Show full item record

SCOPUSTM   
Citations

28
checked on Oct 14, 2024

WEB OF SCIENCETM
Citations

27
checked on Oct 2, 2024

Page view(s)

95
checked on Nov 5, 2024

Download(s)

34
checked on Nov 5, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons